Article
Identification of prognostic values defined by copy number variation, mRNA and protein expression of LANCL2 and EGFR in glioblastoma patients.
Journal of translational medicine - 30 Aug 2021
Zhao Hua-Fu, Zhou Xiu-Ming, Wang Jing, Chen Fan-Fan, Wu Chang-Peng, Diao Peng-Yu, Cai Lin-Rong, Chen Lei, Xu Yan-Wen, Liu Jing, Li Zong-Yang, Liu Wen-Lan, Chen Zhong-Ping, Huang Guo-Dong, Li Wei-Ping
Abstract excerpt
BACKGROUND: Epidermal growth factor receptor (EGFR) and lanthionine synthetase C-like 2 (LanCL2) genes locate in the same amplicon, and co-amplification of EGFR and LANCL2 is frequent in glioblastoma. However, the prognostic value of LANCL2 and EGFR co-amplification, and their mRNA and protein expression in glioblastoma remain unclear yet. METHODS: This study analyzed the prognostic values of the copy number...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
